In this “Q3 2020 Edition” we introduce two NEW BUHLMANN Products. The new FDA Exempt, fecal Pancreatic Elastase (fPELA®) turbo assay, as well newly developed Quantum Blue® 3 Reader (QB3). Also watch the IBDoc® video ‘Want to improve care for IBD patients?’ and lastly watch Dr. Arne Roseth’s AMLI presentation “The latest on IBD Care utilizing Fecal Calprotectin and Therapeutic Drug Monitoring”.
- Products & Solutions
- FDA IVD
- About Us
- News & Events
- Contact
- Additional Sites
